India’s dialysis machines market to hit $14m in 2033 | Healthcare Asia Magazine
, India
138 views
Photo from Envato

India’s dialysis machines market to hit $14m in 2033

The sector currently accounts for approximately 3% of the Asia Pacific market.

India's dialysis machines market is projected to reach $14m by 2033, driven by the prevalence and burden of chronic kidney disorders, said GlobalData.

The country’s sector currently accounts for approximately 3% of the Asia Pacific market with most machines being imported, contributing to higher costs.

In a notable development, Nephro Care India Limited, in collaboration with the National Institute of Technology, Silchar, is developing a prototype of a remotely monitored, AI-enabled machine, aiming to reduce costs by nearly 75% to around $2,368.5 (INR 200,000).

Meanwhile, GlobalData’s medical devices analyst, Shreya Jain, said that whilst the availability of haemodialysis machines has improved, challenges in access, affordability, and quality of care remain.

“Local production support and infrastructure could help manufacturers tailor machines to India’s needs and reduce maintenance expenses, making dialysis more affordable and accessible,” the analyst said.

INR 1 = $0.012

Follow the link s for more news on

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Exclusives

NUHCS to start using breakthrough drug for rare lung condition
Winrevair, which treats hypertension from constricted lung arteries, costs  $3,700-$6,730
Healthcare
Singapore’s aged care homes fall short
Their services are routinary and not personalised mainly due to resource constraints.
Healthcare
Electronic health records with AI show promise
They are also at risk from backdoor attacks, data poisoning and unauthorised access.